The present invention relates devices for injecting, infusing, delivering, dispensing or administering substances, and to methods of making and using such devices. More particularly, it relates to an ambulatory medical device and a method of communication for or communicating between or among medical devices.
Ambulatory medical devices include devices for the treatment of diabetes, e.g. extra corporal insulin pumps and blood glucose measuring devices such as hand held glucose meters. Insulin pumps allow a good control of blood glucose concentrations by continuously infusing a basic amount of insulin in a human body (basal insulin rate) and by allowing manually controlled delivery of additional “meal bolus” insulin quantities thereby reflecting the insulin secretion by the pancreas. Furthermore, the development of continuous glucose sensors will allow measuring in vivo glucose concentrations over the whole day. The measured glucose date can be used to adjust the diabetes therapy to individual needs.
To improve the treatment of medical conditions, including diabetes, it would be helpful to provide a way to transfer data and/or communicate information between and/or among medical devices in a way that assures optimal quality and accuracy of the function of the devices, the information being communicated, and the exchange of the information.
It is an object of the present invention to provide a medical system and method providing a controlled data transfer between medical devices.
In one embodiment, the present invention comprises a medical device comprising a module for communication with at least a second medical device wherein the module for communication in the medical device is adapted to be activated by a value of a physiological parameter of an animal.
In one embodiment, the medical device and/or devices comprise a telemetry system or feature for wireless communication, e.g. in one preferred embodiment, a telemetry system for RF communication.
In some preferred embodiments, the medical device is selected from the group consisting of a remote control, a PDA, an analyte measuring device, e.g., a glucose measuring device such as a hand held glucose meter, a strip based or strip type glucose meter, or combinations thereof.
In some embodiments, the physiological parameter may be selected from the group consisting of an analyte concentration, a physiological characteristic like conductivity of an animal, a physiological vital sign such as heart or breath rate, temperature, movement, air- or structure-borne sound, ECG (electrocardiogram), etc. In one preferred embodiment of the present invention, the analyte concentration is a blood glucose concentration.
In some preferred embodiments, the medical device of the present invention comprises an electrochemical or photometric module for measuring blood glucose. Suitable medical devices are include strip based glucose meters such as the meter known as the AccuChek Compact.
In one embodiment, the present invention relates to and/or comprises a system of medical devices. The system comprises a first medical device of the present invention as described above and at least a second medical device capable of communicating with the first medical device.
In one preferred embodiment, the second medical device may be selected from the group consisting of an extra corporal infusion pump, an implantable infusion pump, a pacesetter, an analyte or vital sign sensor, a continuous analyte or vital sign sensor, and a continuous glucose sensor.
In another preferred embodiment, the first medical device and the at least second medical device comprise a telemetry system for wireless communication, in some preferred embodiments, a telemetry system for RF communication.
In another aspect, the present invention relates to or comprises a method of communication between a first medical device and at least a second medical device wherein the communication between said medical devices is enabled and/or activated by a value of a physiological parameter of an animal. In a preferred embodiment, the communication between the at least two medical devices is enabled and/or activated for a predetermined time. The time duration can be fixed, random, dependent on the physiological parameter enabling and/or activating the communication, or dependent on other physiological parameters of the animal body.
In some preferred embodiments, the physiological parameter may be selected from the group consisting of an analyte concentration, a physiological characteristic like conductivity of an animal, a physiological vital sign like heart or breath rate, temperature, movement, air- or structure-borne sound, ECG (electrocardiogram), etc. In some preferred embodiments, the analyte concentration is a blood glucose concentration.
In one preferred embodiment, the activation of communication between the medical devices is performed on the first medical device by a value of the physiological parameter.
In some preferred embodiments, the first medical device may be selected from the group consisting of a remote control, a PDA, an analyte measuring device, a glucose measuring device, and a strip based glucose meter. The second medical device may be selected from the group consisting of an extra corporal infusion pump, an implantable infusion pump, a pacesetter, an analyte sensor, a continuous analyte sensor, and a continuous glucose sensor.
In one preferred embodiment, the communication between the medical devices is a wireless communication, e.g., a RF communication. In other preferred embodiments, other suitable forms or methods of communicating information, sensed parameters, data, commands, etc. may be used.
In one preferred embodiment, the first medical device receives data or information from the second medical device, and in another preferred embodiment, the first medical device sends commands to the second medical device controlling at least partially the function or operation of the second medical device.
With regard to fastening, mounting, attaching or connecting components of the present invention, unless specifically described as otherwise, conventional mechanical fasteners and methods may be used. Other appropriate fastening or attachment methods include adhesives, welding and soldering, the latter particularly with regard to the electronics associated with the invention, if any. Suitable electrical components and circuitry, wires, wireless components, chips, boards, microprocessors, receivers, transmitters, inputs, outputs, displays, control components, etc. may be used. Generally, unless otherwise indicated, the materials used in the invention and/or its components may be selected from appropriate materials such as metal, metallic alloys, ceramics, plastics, etc.
In one aspect, the present invention relates to a method for controlling and/or enabling communication between medical devices, such as medical sensory devices such as continuous glucose sensors and/or therapeutic devices such as insulin pumps and/or diagnostic medical devices such as glucose meters.
For example, referring to
The term “generation of a value” as it is used herein encompasses any method or procedure for the determination of physiological parameters such as methods for the measurement of analyte values, e.g., blood glucose values. Suitable methods for the determination of blood glucose values include electrochemical methods, photometric methods and others which are known to a person skilled in the art.
The dependence of the communication link between medical devices on an actual analyte value ensures the quality of the data transmitted from the medical sensory device and/or medical therapeutical device to the medical diagnostic device.
The data transferred from the sensor 4 to the diagnostic device, e.g., the meter 6, can be stored on the diagnostic device and be transferred, as represented by arrow B to a third device 8 such as a PDA or a computer, for further processing and/or analysis. The data can be analyzed and/or processed by suitable software and used, for example, for bolus recommendation or adjustment of basal insulin rates for patients using an extra- or intra corporal insulin pump. The communication link between the diagnostic device 6 and a third device 8 does not necessarily need activation by generation of a blood glucose value in the diagnostic device 6.
Referring to
With further reference to
The data transfer between the medical devices can be performed using known and/or available technologies, and may comprise wired and/or wireless components, connections and/or communications. These technologies are known to a person skilled in the art. In one preferred embodiment, communication may be provided RF communication. In some embodiments, the data transfer between the devices can be encrypted to ensure that non-authorized third parties do not gain access to personal data of patients. Any suitable method of encrypting data, including those known to a person skilled in the art, may be used. In some preferred embodiments, the communication between the medical devices may be activated by a manipulation of or on the second medical device, e.g. insulin pump 12, such as pressing a button or lever, inserting a battery, using the touch screen, shaking, bumping or squeezing or the like.
Referring to
The communication between the devices, i.e. the wireless link, is established and/or activated by measuring the glucose concentration in a blood sample of a patient using the glucose meter 22. When a strip-based glucose meter is used, the patient inserts a strip in the glucose meter and puts a droplet of blood on the strip. The glucose meter 22 measures and indicates the blood glucose value, e.g., on an associated display. After measurement of the blood glucose value, the communication link can then be activated/established either by, for example, pressing an input on the glucose meter 22, e.g. an activation button, or by a direct electronic link to the processor 26 controlling the glucose telemetry system 30 such that the completion of the blood glucose measurement automatically activates the wireless link between the devices.
The communication link is then established and a data transfer between the medical devices is possible and/or occurs for a defined time span. After expiration of the defined time span the communication link is deactivated and no further data/commands can be transmitted between the medical devices. A new blood glucose measurement in the glucose meter 22 is then necessary to open a new wireless link between the medical devices.
In a further aspect, the present invention relates to a method of data processing or data use, wherein the data processing or data use is only possible and/or only occurs after activation by a value of a physiological parameter. The method is may be used for the processing of medical data such as data measured by a sensor applied on a human body.
Referring to
In some preferred embodiments, there is a permanent communication link between said two medical devices, but the data stored in a memory 39 of the medical sensor device 34 and transferred to the diagnostic device 36 can only be further processed on the diagnostic device 36 after the processing has been activated by a value of a physiological parameter. After activation by a value of a physiological parameter, preferably a blood glucose value, the data stored in the memory 39 of the diagnostic device 36 can be processed or used. For example, data are transferred from a continuous glucose sensor 34 to a glucose meter 36 and stored in the memory of the glucose meter. The further processing of these data is then only possible after activation of the processing by a value of a physiological parameter, e.g., a blood glucose value. In one preferred embodiment, the processing of the data is only possible for a limited time span after activation by a value of a physiological parameter. When the defined time span for data processing has lapsed, no further data processing is possible without a new activation by a value of a physiological parameter.
Referring to
Embodiments of the present invention, including preferred embodiments, have been presented for the purpose of illustration and description. They are not intended to be exhaustive or to limit the invention to the precise forms and steps disclosed. The embodiments were chosen and described to provide the best illustration of the principles of the invention and the practical application thereof, and to enable one of ordinary skill in the art to utilize the invention in various embodiments and with various modifications as are suited to the particular use contemplated. All such modifications and variations are within the scope of the invention as determined by the appended claims when interpreted in accordance with the breadth they are fairly, legally, and equitably entitled.
Number | Date | Country | Kind |
---|---|---|---|
05002074 | Feb 2005 | EP | regional |
This application is a continuation of International Application No. PCT/EP2006/000663, filed on Jan. 26, 2006, which claims priority to European Patent Application No. 05 002 074.2, filed on Feb. 2, 2005, the contents of both of which are incorporated in their entirety herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
5507288 | Bocker et al. | Apr 1996 | A |
6290646 | Cosentino et al. | Sep 2001 | B1 |
6295506 | Heinonen et al. | Sep 2001 | B1 |
6553244 | Lesho et al. | Apr 2003 | B2 |
6572543 | Christopherson et al. | Jun 2003 | B1 |
6641533 | Causey et al. | Nov 2003 | B2 |
6659948 | Lebel | Dec 2003 | B2 |
7034677 | Steinthal et al. | Apr 2006 | B2 |
7276029 | Goode et al. | Oct 2007 | B2 |
7278983 | Ireland et al. | Oct 2007 | B2 |
20020010390 | Guice et al. | Jan 2002 | A1 |
20020016568 | Lebel | Feb 2002 | A1 |
20020049389 | Abreu | Apr 2002 | A1 |
20020143241 | Thorell | Oct 2002 | A1 |
20020151770 | Noll et al. | Oct 2002 | A1 |
20030041866 | Linberg | Mar 2003 | A1 |
20030065536 | Hansen et al. | Apr 2003 | A1 |
20030114898 | Von Arx | Jun 2003 | A1 |
20030136418 | Behm | Jul 2003 | A1 |
20040077995 | Ferek-Petric | Apr 2004 | A1 |
20040102971 | Lipscher et al. | May 2004 | A1 |
20040116786 | Iijima et al. | Jun 2004 | A1 |
20040122702 | Sabol et al. | Jun 2004 | A1 |
20040167464 | Ireland et al. | Aug 2004 | A1 |
20040225338 | Lebel et al. | Nov 2004 | A1 |
20050080322 | Korman | Apr 2005 | A1 |
20050113717 | Matzinger et al. | May 2005 | A1 |
20050182306 | Sloan | Aug 2005 | A1 |
20050192557 | Brauker et al. | Sep 2005 | A1 |
20050195930 | Spital | Sep 2005 | A1 |
20070282177 | Pilz | Dec 2007 | A1 |
20100179409 | Kamath | Jul 2010 | A1 |
Number | Date | Country |
---|---|---|
0 098 592 | Jan 1984 | EP |
Number | Date | Country | |
---|---|---|---|
20080033255 A1 | Feb 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/EP2006/000663 | Jan 2006 | US |
Child | 11832421 | US |